Clinical Observation Trials

CONNECT_MM Study: For patients with newly diagnosed multiple myeloma

Biovica Divitum Study: For patients with HR+ Metastatic Breast Cancer

Clinical Treatment Trials

ABEMA Study: For patients with ER+ HER2- Early Breast Cancer

Therapy on Trial: Giredestrant and Abemaciclib

ASCENT-05 Study: For patients who completed chemotherapy followed by surgery

Therapy on Trial: Sacituzumab Govetican and Pembrolizumab

TAILOR Study: For patients who have not received treatment for their CLL

Therapy on Trial: Ibrutinib & Venetoclax OR Ibrutinib Alone

COCOON Study: For patients who have not received treatment for their locally advanced/metastatic EGFR mutated NSCLC

Therapy on Trial: Amivantamab & Lazertinib with dermatological medications

REC-4881-221 LILAC Study: For patients with an AXIN1 or APC mutation for locally advanced or metastatic cancer

Therapy on Trial: REC-4881 Drug